ArticleFEBS open bio2021

Tislelizumab uniquely binds to the CC' loop of PD-1 with slow-dissociated rate and complete PD-L1 blockage.

Yuan Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.